Martínez-Bautista María José, Mangues-Bafalluy Irene, Cajaraville-Ordoñana Gerardo, Carreras-Soler María Josep, Clopés-Estela Ana, Moreno-Martínez Estela
Pharmacy Service, Puerta del Mar University Hospital, Cádiz.
Pharmacy Service, Arnau de Vilanova Hospital, Lleida.
Farm Hosp. 2019 Nov 1;43(6):194-201. doi: 10.7399/fh.11239.
To learn about the baseline of Oncohematological Pharmacy Units in Spanish hospitals in order to identify areas for improvement.
A survey in line with the objectives set in GEDEFO 2020 Strategic Plan of Pharmaceutical Care for oncohematological patients was designed. The survey was hosted on GEDEFO's website during March and April 2017. Activity data for 2016 was collected. Results: A total of 95 hospitals responded to the survey. Out of which, 76% had an integrated information system of pharmacotherapeutic process management, where a variability in technological and organizational processes were found. The oncohematological pharmacist led the implementation of the principles of medicine, based on evidence and results obtained in routine clinical practice. It was shown that 88% of hospitals had standardized protocols. As for safety practices, in 83% of hospitals, oncohematological pharmacists actively participated in the development and maintenance of risk management program, implemented to prevent errors. Preparation was centralized in 89% of hospitals. Variability was observed in pharmaceutical care depending on where the patient was attended. In 92% of hospitals, pharmacists served as reference for Oncohematology, although with different levels of training. Major deficiencies were observed in training programs and teaching. Of all oncohematological pharmacists, 53% had been a researcher over the past three years.
These results mark the starting point for Spanish Oncohematological Pharmacy Units to develop strategies for improving the quality of pharmaceutical care offered to oncohematological patients and led by GEDEFO, heads of service, and oncohematological patients themselves.
了解西班牙医院血液肿瘤药学部门的基线情况，以确定改进领域。
设计了一项与GEDEFO 2020年血液肿瘤患者药学照护战略计划设定的目标相符的调查。该调查于2017年3月和4月在GEDEFO网站上进行。收集了2016年的活动数据。
共有95家医院回复了调查。其中，76%拥有药物治疗过程管理综合信息系统，在技术和组织流程方面存在差异。血液肿瘤药师依据常规临床实践中获得的证据和结果，主导了医学原则的实施。结果显示，88%的医院有标准化方案。在安全实践方面，83%的医院中，血液肿瘤药师积极参与了为预防差错而实施的风险管理计划的制定和维护。89%的医院制剂制备是集中进行的。根据患者就诊地点的不同，药学照护存在差异。92%的医院中，药师担任血液肿瘤学的咨询人员，尽管培训水平各不相同。在培训项目和教学方面存在重大不足。在所有血液肿瘤药师中，53%在过去三年中曾是研究人员。
这些结果标志着西班牙血液肿瘤药学部门在GEDEFO、科室主任和血液肿瘤患者自身的引领下，制定提高为血液肿瘤患者提供的药学照护质量策略的起点。
